Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Teijin America, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Type 2 diabetes treated with ≥1 glucose-lowering medication for at least 12 months
UACR 200 to 3000 mg/g
eGFR ≥30 ml/min/1.73m2
Treated with at least the minimal recommended dose of an angiotensin converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker (ARB), but not both
You may not be if
History of Type 1 diabetes
Women who are breast feeding
Treatment with any uric acid-lowering therapy within previous 2 weeks
History of intolerance to any XO (xanthine oxidase) inhibitor
History of a gout flare requiring pharmacologic treatment
History or presence of tophaceous gout
History of immunosuppressant treatment for any known or suspected renal disorder
History of a non-diabetic form of renal disease
Glycosylated hemoglobin (HbA1c) \>11%
sUA \<4.0 mg/dL or \>10.0 mg/dL
Positive urinary pregnancy test
Dialysis for acute renal failure within previous 6 months
Renal allograft in place or a scheduled kidney transplant within the next 22 weeks
